Abstract
In the realm of healthcare and the advancing field of medical sciences, the development of efficient drug delivery systems become an immense promise to cure several diseases. Despite considerable advancements in drug delivery systems, numerous challenges persist, necessitating further enhancements to optimize patient outcomes. Smart nano-carriers, for instance, 2D sheets nano-carriers are the recently emerging nanosheets that may garner attention for targeted delivery of bioactive compounds, drugs, and genes to kill cancer cells. Within these advancements, Ti3C2TX-MXene, characterized as a two-dimensional transition metal carbide, has surfaced as a prominent intelligent nanocarrier within nanomedicine. Its noteworthy characteristics facilitated it as an ideal nanocarrier for cancer therapy. In recent advancements in drug delivery research, Ti3C2TX-MXene 2D nanocarriers have been designed to release drugs in response to specific stimuli, guided by distinct physicochemical parameters. This review emphasized the multifaceted role of Ti3C2TX-MXene as a potential carrier for delivering poorly hydrophilic drugs to cancer cells, facilitated by various polymer coatings. Furthermore, beyond drug delivery, this smart nanocarrier demonstrates utility in photoacoustic imaging and photothermal therapy, further highlighting its significant role in cellular mechanisms.
Graphical Abstract
Similar content being viewed by others
Data availability
No data was used for the research described in the article.
Abbreviations
- Ti3C2 :
-
Titanium Carbide
- VEGFR:
-
Vascular endothelial growth factor receptor
- mAb:
-
Monoclonal antibody
- PD1:
-
Programmed cell death receptor-1
- IV:
-
Intravenous
- SC:
-
Subcutaneous
- GI:
-
Gastrointestinal tract
- −F:
-
Fluorine
- −O:
-
Oxygen
- −OH:
-
Hydroxyl
- Ti3AlC2 :
-
Titanium aluminum carbide
- UV:
-
Ultraviolet
- Nm:
-
Nanometer
- NIR:
-
Near-infrared
- PEG:
-
Polyethylene glycol
- PVP:
-
Polyvinylpyrrolidone
- Nb2C:
-
Niobium Carbide
- Pt:
-
Platinum
- DOX:
-
Doxorubicin
- HeLa:
-
Henrietta Lacks
- CT:
-
Computed tomography
- MRI:
-
Magnetic Resonance Imaging
- EPR:
-
Enhanced permeability and retention
- PA:
-
Photoacoustic
- ICP-OES:
-
Inductively coupled plasma optical emission spectrometry
- pH:
-
Potential of Hydrogen
- ROS:
-
Reactive oxygen species
- O2– :
-
Superoxide anion
- H2O2 :
-
Hydrogen peroxide
- IR:
-
Ionizing radiation
- SOD:
-
Superoxide dismutase
- MDA:
-
Malondialdehyde
- IL:
-
Ionic liquids
- IL-1β:
-
Interleukin-1 beta
- IL-6:
-
Interleukin 6
- TNF-α:
-
Tumour Necrosis Factor alpha
- HepG2:
-
Hepatoblastoma cell line
- CD44:
-
Cluster of Differentiation 44
- NPD:
-
Nb2C plasmon (MXene), Pt nanozymes, doxorubicin
- DLS:
-
Dynamic light scattering
- PBS:
-
Phosphate buffered saline
- DMEM:
-
Dulbecco’s Modified Eagle Medium
- CD:
-
Carbon dots
- SP:
-
Soybean phospholipid
- HA:
-
Hyaluronic acid
- MOF:
-
Metal-organic frameworks
- CRISPR:
-
Clustered regularly interspaced short palindromic repeats
- PDA:
-
Polydopamine
- JC-1:
-
Tetraethylbenzimi-dazoylcarbocyanine iodide
- EGCG:
-
Epigallocatechin gallate
- TPOM:
-
Ti3C2-PEG-OVA-Mn2+
- DC:
-
Dendritic cell
- PTT:
-
Photothermal therapy
- Mn2+ :
-
Manganese (2+)
- STING:
-
Stimulator of interferon genes
- DNA:
-
Deoxyribonucleic acid
- CD80:
-
Cluster of Differentiation 80
- CD86:
-
Cluster of Differentiation 86
- CD11c:
-
Cluster of Differentiation 11c
- MHC-II:
-
Major histocompatibility complex class II
- IFN-β:
-
Interferon-β
- NF-κB:
-
Nuclear factor kappa B
- WNT:
-
Wingless-related integration site
- HIF-1α:
-
Hypoxia-inducible factor 1-alpha
- PCR:
-
Polymerase chain reaction
- ATM:
-
Ataxia-Telangiectasia mutated
- CHK2:
-
Checkpoint kinase 2
- CDK4:
-
Cyclin-Dependent Kinase 4
- Na+ :
-
Sodium (1+)
- K+ :
-
Potassium (1+)
- ATPase:
-
Adenosine triphosphatase
- BMP2:
-
Bone Morphogenetic Protein 2
References
Akens MK, Hardisty MR, Wilson BC, Schwock J, Whyne CM, Burch S, et al. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin). Breast Cancer Res Treat. 2010;119:325–33.
Watanabe K, Kuramitsu S, Posey AD, June CH. Expanding the therapeutic window for CAR T cell therapy in solid tumors: the knowns and unknowns of CAR T Cell Biology. Front Immunol. 2018;9:9.
Stein F, Schielke A, Barcikowski S, Rehbock C. Influence of gold/silver ratio in ablative nanoparticles on their interaction with aptamers and functionality of the obtained conjugates. Bioconjug Chem. 2021;32:2439–46.
Zhang W, Taheri-Ledari R, Hajizadeh Z, Zolfaghari E, Ahghari MR, Maleki A, et al. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide. Nanoscale. 2020;12:3855–70.
Guilbaud-Chéreau C, Dinesh B, Schurhammer R, Collin D, Bianco A, Ménard-Moyon C. Protected amino acid–based hydrogels incorporating carbon nanomaterials for near-infrared irradiation-triggered drug release. ACS Appl Mater Interfaces. 2019;11:13147–57.
Saha A, Basiruddin S, Maity AR, Jana NR. Synthesis of nanobioconjugates with a controlled average number of biomolecules between 1 and 100 per nanoparticle and observation of multivalency dependent interaction with proteins and cells. Langmuir. 2013;29:13917–24.
Tang W, Dong Z, Zhang R, Yi X, Yang K, Jin M, et al. Multifunctional two-dimensional core–shell MXene@gold nanocomposites for enhanced photo–radio combined therapy in the second biological window. ACS Nano. 2019;13:284–94.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Lorscheider M, Gaudin A, Nakhlé J, Veiman K-L, Richard J, Chassaing C. Challenges and opportunities in the delivery of cancer therapeutics: update on recent progress. Ther Deliv. 2021;12:55–76.
Trojan J. Cabozantinib for the treatment of advanced hepatocellular carcinoma: current data and future perspectives. Drugs. 2020;80:1203–10.
Duke ES, Barone AK, Chatterjee S, Mishra-Kalyani PS, Shen Y-L, Isikwei E, et al. FDA approval summary: cabozantinib for differentiated thyroid cancer. Clin Cancer Res. 2022;28:4173–7.
Koppolu V, Rekha Vasigala VK. Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma. J Cancer Res Ther. 2018;14:1167–75.
Jácome AA, Eng C. Role of immune checkpoint inhibitors in the treatment of colorectal cancer: focus on nivolumab. Expert Opin Biol Ther. 2019;19:1247–63.
Subklewe M, von Bergwelt-Baildon M, Humpe A. Chimeric antigen receptor T cells: a race to revolutionize cancer therapy. Transfus Med Hemotherapy. 2019;46:15–24.
Lewis AL, Richard J. Challenges in the delivery of peptide drugs: an industry perspective. Ther Deliv. 2015;6:149–63.
Richard J. Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects. Ther Deliv. 2017;8:663–84.
Collins DS, Kourtis LC, Thyagarajapuram NR, Sirkar R, Kapur S, Harrison MW, et al. Optimizing the bioavailability of subcutaneously administered biotherapeutics through mechanochemical drivers. Pharm Res. 2017;34:2000–11.
Richter WF, Jacobsen B. Subcutaneous absorption of biotherapeutics: knowns and unknowns. Drug Metab Dispos. 2014;42:1881–9.
Kinnunen HM, Sharma V, Contreras-Rojas LR, Yu Y, Alleman C, Sreedhara A, et al. A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components. J Controlled Release. 2015;214:94–102.
Mathaes R, Koulov A, Joerg S, Mahler H-C. Subcutaneous injection volume of biopharmaceuticals—pushing the boundaries. J Pharm Sci. 2016;105:2255–9.
Dias C, Abosaleem B, Crispino C, Gao B, Shaywitz A. Tolerability of high-volume subcutaneous injections of a viscous placebo buffer: a randomized, crossover study in healthy subjects. AAPS PharmSciTech. 2015;16:1101–7.
Alhabeb M, Maleski K, Anasori B, Lelyukh P, Clark L, Sin S, et al. Guidelines for synthesis and processing of two-dimensional titanium Carbide (Ti3C2Tx MXene). Chem Mater. 2017;29:7633–44.
Anasori B, Xie Y, Beidaghi M, Lu J, Hosler BC, Hultman L, et al. Two-dimensional, ordered, double transition metals carbides (MXenes). ACS Nano. 2015;9:9507–16.
Kim H, Alshareef HN. MXetronics: MXene-enabled electronic and photonic devices. ACS Mater Lett. 2020;2:55–70.
Naguib M, Kurtoglu M, Presser V, Lu J, Niu J, Heon M, et al. Two-dimensional nanocrystals produced by exfoliation of Ti3AlC2. Adv Mater. 2011;23:4248–53.
Xie Z, Chen S, Duo Y, Zhu Y, Fan T, Zou Q, et al. Biocompatible two-dimensional titanium nanosheets for multimodal imaging-guided cancer theranostics. ACS Appl Mater Interfaces. 2019;11:22129–40.
Feng X-Y, Ding B-Y, Liang W-Y, Zhang F, Ning T-Y, Liu J, et al. MXene Ti3C2Tx absorber for a 1.06 µm passively Q-switched ceramic laser. Laser Phys Lett. 2018;15:085805.
Wang C, Wang Y, Jiang X, Xu J, Huang W, Zhang F, et al. MXene Ti3C2Tx: a promising photothermal conversion material and application in all-optical modulation and all-optical information loading. Adv Opt Mater. 2019;7:1900060.
Wu Q, Chen S, Wang Y, Wu L, Jiang X, Zhang F, et al. MZI-based all-optical modulator using MXene Ti3C2Tx (T = F, 0, or OH) deposited microfiber. Adv Mater Technol. 2019;4:1800532.
Zhan X, Si C, Zhou J, Sun Z. MXene and MXene-based composites: synthesis, properties and environment-related applications. Nanoscale Horiz. 2020;5:235–58.
Iravani S, Varma RS. MXenes and MXene-based materials for tissue engineering and regenerative medicine: recent advances. Mater Adv. 2021;2:2906–17.
Jastrzębska A, Karwowska E, Basiak D, Zawada A, Ziemkowska W, Wojciechowski T, et al. Biological activity and bio-sorption properties of the Ti2C studied by means of zeta potential and SEM. Int J Electrochem Sci. 2017;12:2159–72.
Szuplewska A, Kulpińska D, Dybko A, Chudy M, Jastrzębska AM, Olszyna A, et al. Future applications of MXenes in biotechnology, nanomedicine, and sensors. Trends Biotechnol. 2020;38:264–79.
Wang Y, Feng W, Chen Y. Chemistry of two-dimensional MXene nanosheets in theranostic nanomedicine. Chin Chem Lett. 2020;31:937–46.
Naguib M, Mashtalir O, Carle J, Presser V, Lu J, Hultman L, et al. Two-dimensional transition metal carbides. ACS Nano. 2012;6:1322–31.
Ronchi RM, Arantes JT, Santos SF. Synthesis, structure, properties and applications of MXenes: current status and perspectives. Ceram Int. 2019;45:18167–88.
Rasool K, Helal M, Ali A, Ren CE, Gogotsi Y, Mahmoud KA. Antibacterial activity of Ti3C2Tx MXene. ACS Nano. 2016;10:3674–84.
Chen K, Qiu N, Deng Q, Kang M-H, Yang H, Baek J-U, et al. Cytocompatibility of Ti3AlC2, Ti3SiC2, and Ti2AlN: in vitroTests and first-principles calculations. ACS Biomater Sci Eng. 2017;3:2293–301.
Huang J, Li Z, Mao Y, Li Z. Progress and biomedical applications of MXenes. Nano Select. 2021;2:1480–508.
Chaudhuri K, Wang Z, Alhabeb M, Maleski K, Gogotsi Y, Shalaev V, et al. Optical properties of MXenes. 2D metal carbides and nitrides (MXenes). Cham: Springer International Publishing; 2019. p. 327–46.
Berdiyorov GR. Optical properties of functionalized Ti3C2T2 (T = F, O, OH) MXene: first-principles calculations. AIP Adv. 2016;6:055105.
Li J, Qin R, Yan L, Chi Z, Yu Z, Li N, et al. Plasmonic light illumination creates a channel to achieve fast degradation of Ti3C2Tx nanosheets. Inorg Chem. 2019;58:7285–94.
Fu B, Sun J, Wang C, Shang C, Xu L, Li J, et al. MXenes: synthesis, optical properties, and applications in ultrafast photonics. Small. 2021;17:2006054.
Li R, Zhang L, Shi L, Wang P. MXene Ti3C2: an effective 2D light-to-heat conversion material. ACS Nano. 2017;11:3752–9.
Wu F, Zheng H, Wang W, Wu Q, Zhang Q, Guo J, et al. Rapid eradication of antibiotic-resistant bacteria and biofilms by MXene and near-infrared light through photothermal ablation. Sci China Mater. 2021;64:748–58.
Szuplewska A, Kulpińska D, Dybko A, Jastrzębska AM, Wojciechowski T, Rozmysłowska A, et al. 2D Ti2C (MXene) as a novel highly efficient and selective agent for photothermal therapy. Mater Sci Engineering: C. 2019;98:874–86.
Xu Y, Wang Y, An J, Sedgwick AC, Li M, Xie J, et al. 2D-ultrathin MXene/DOXjade platform for iron chelation chemo-photothermal therapy. Bioact Mater. 2022;14:76–85.
Hao Z, Li Y, Liu X, Jiang T, He Y, Zhang X, et al. Enhancing biocatalysis of a MXene-based biomimetic plasmonic assembly for targeted cancer treatments in NIR-II biowindow. Chem Eng J. 2021;425: 130639.
Li G, Zhong X, Wang X, Gong F, Lei H, Zhou Y, et al. Titanium carbide nanosheets with defect structure for photothermal-enhanced sonodynamic therapy. Bioact Mater. 2022;8:409–19.
Bai Z, Zhao L, Feng H, Xin Z, Wang C, Liu Z, et al. Aptamer modified Ti3C2 nanosheets application in smart targeted photothermal therapy for cancer. Cancer Nanotechnol. 2023;14:35.
Lin Y, Xu S, Zhao X, Chang L, Hu Y, Chen Z, et al. Preparation of NIR-sensitive, photothermal and photodynamic multi-functional mxene nanosheets for laryngeal cancer therapy by regulating mitochondrial apoptosis. Mater Des. 2022;220: 110887.
Liu Y, Han Q, Yang W, Gan X, Yang Y, Xie K, et al. Two-dimensional MXene/cobalt nanowire heterojunction for controlled drug delivery and chemo-photothermal therapy. Mater Sci Engineering: C. 2020;116: 111212.
Liu K, Liao Y, Zhou Z, Zhang L, Jiang Y, Lu H, et al. Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity. Biomaterials. 2022;282: 121383.
Han X, Huang J, Lin H, Wang Z, Li P, Chen Y. 2D ultrathin MXene-based drug-delivery nanoplatform for synergistic photothermal ablation and chemotherapy of Cancer. Adv Healthc Mater. 2018;7:1701394.
Lu B, Hu S, Wu D, Wu C, Zhu Z, Hu L, et al. Ionic liquid exfoliated Ti3C2Tx MXene nanosheets for photoacoustic imaging and synergistic photothermal/chemotherapy of cancer. J Mater Chem B. 2022;10:1226–35.
Jastrzębska AM, Szuplewska A, Wojciechowski T, Chudy M, Ziemkowska W, Chlubny L, et al. In vitro studies on cytotoxicity of delaminated Ti3C2 MXene. J Hazard Mater. 2017;339:1–8.
Wang J, Zhang Y, Jin N, Mao C, Yang M. Protein-induced gold nanoparticle assembly for improving the photothermal effect in cancer therapy. ACS Appl Mater Interfaces. 2019;11:11136–43.
Zhou M, Zhou Y, Cheng Y, Wu Y, Yang J, Lv Z. Application of gold-based nanomaterials in tumor photothermal therapy and chemotherapy. J Biomed Nanotechnol. 2020;16:739–62.
Ivošev V, Sánchez GJ, Stefancikova L, Haidar DA, González Vargas CR, Yang X, et al. Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblasts. Nanotechnology. 2020;31:135102.
Ding L, Chang Y, Yang P, Gao W, Sun M, Bie Y, et al. Facile synthesis of biocompatible L-cysteine-modified MoS2 nanospheres with high photothermal conversion efficiency for photothermal therapy of tumor. Mater Sci Engineering: C. 2020;117: 111371.
Hao J, Song G, Liu T, Yi X, Yang K, Cheng L, et al. In Vivo long-term biodistribution, excretion, and toxicology of PEGylated transition-metal dichalcogenides MS2 (M = Mo, W, Ti) nanosheets. Adv Sci. 2017;4:1600160.
Sui B, Liu X, Sun J. Biodistribution, inter-/intra-cellular localization and respiratory dysfunction induced by Ti3C2 nanosheets: involvement of surfactant protein down-regulation in alveolar epithelial cells. J Hazard Mater. 2021;402: 123562.
Gao W, Xu K, Ji L, Tang B. Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. Toxicol Lett. 2011;205:86–95.
Zong L, Wu H, Lin H, Chen Y. A polyoxometalate-functionalized two-dimensional titanium carbide composite MXene for effective cancer theranostics. Nano Res. 2018;11:4149–68.
Lin H, Wang X, Yu L, Chen Y, Shi J. Two-dimensional ultrathin MXene ceramic nanosheets for photothermal conversion. Nano Lett. 2017;17:384–91.
Mei X, Hu T, Wang Y, Weng X, Liang R, Wei M. Recent advancements in two-dimensional nanomaterials for drug delivery. WIREs Nanomed Nanobiotechnol. 2020;12:e1596.
Ren X, Huo M, Wang M, Lin H, Zhang X, Yin J, et al. Highly catalytic niobium carbide (MXene) promotes hematopoietic recovery after radiation by free radical scavenging. ACS Nano. 2019;13:6438–54.
Zhang J, Li S, Hu S, Zhou Y. Chemical Stability of Ti3C2 MXene with Al in the temperature range 500–700°C. Materials. 2018;11: 1979.
Tian W, VahidMohammadi A, Wang Z, Ouyang L, Beidaghi M, Hamedi MM. Layer-by-layer self-assembly of pillared two-dimensional multilayers. Nat Commun. 2019;10:2558.
Zhang D-Y, Xu H, He T, Younis MR, Zeng L, Liu H, et al. Cobalt carbide-based theranostic agents for in vivo multimodal imaging guided photothermal therapy. Nanoscale. 2020;12:7174–9.
Shurbaji S, Manaph NPA, Ltaief SM, Al-Shammari AR, Elzatahry A, Yalcin HC. Characterization of MXene as a cancer photothermal agent under physiological conditions. Front Nanatechnol. 2021;3:689718.
Yang J, Bao W, Jaumaux P, Zhang S, Wang C, Wang G. MXene-based composites: synthesis and applications in rechargeable batteries and supercapacitors. Adv Mater Interfaces. 2019;6:1802004.
Salim O, Mahmoud KA, Pant KK, Joshi RK. Introduction to MXenes: synthesis and characteristics. Mater Today Chem. 2019;14:100191.
Anasori B, Lukatskaya MR, Gogotsi Y. 2D metal carbides and nitrides (MXenes) for energy storage. Nat Rev Mater. 2017;2:16098.
Naguib M, Mochalin VN, Barsoum MW, Gogotsi Y. 25th anniversary article: MXenes: a new family of two-dimensional materials. Adv Mater. 2014;26:992–1005.
Sang X, Xie Y, Lin M-W, Alhabeb M, Van Aken KL, Gogotsi Y, et al. Atomic defects in monolayer titanium carbide (Ti3C2Tx) MXene. ACS Nano. 2016;10:9193–200.
Ghidiu M, Lukatskaya MR, Zhao M-Q, Gogotsi Y, Barsoum MW. Conductive two-dimensional titanium carbide ‘clay’ with high volumetric capacitance. Nature. 2014;516:78–81.
Feng A, Yu Y, Wang Y, Jiang F, Yu Y, Mi L, et al. Two-dimensional MXene Ti3C2 produced by exfoliation of Ti3AlC2. Mater Des. 2017;114:161–6.
Halim J, Lukatskaya MR, Cook KM, Lu J, Smith CR, Näslund L-Å, et al. Transparent conductive two-dimensional titanium carbide epitaxial thin films. Chem Mater. 2014;26:2374–81.
Lipatov A, Alhabeb M, Lukatskaya MR, Boson A, Gogotsi Y, Sinitskii A. Effect of synthesis on quality, electronic properties and environmental stability of individual monolayer Ti3C2 MXene flakes. Adv Electron Mater. 2016;2:1600255.
Naguib M, Unocic RR, Armstrong BL, Nanda J. Large-scale delamination of multi-layers transition metal carbides and carbonitrides MXenes. Dalton Trans. 2015;44:9353–8.
Mashtalir O, Naguib M, Mochalin VN, Dall’Agnese Y, Heon M, Barsoum MW, et al. Intercalation and delamination of layered carbides and carbonitrides. Nat Commun. 2013;4:1716.
Ma R, Sasaki T. Two-dimensional oxide and hydroxide nanosheets: controllable high-quality exfoliation, molecular assembly, and exploration of functionality. Acc Chem Res. 2015;48:136–43.
Bitounis D, Ali-Boucetta H, Hong BH, Min D, Kostarelos K. Prospects and challenges of graphene in biomedical applications. Adv Mater. 2013;25:2258–68.
Yin F, Gu B, Lin Y, Panwar N, Tjin SC, Qu J, et al. Functionalized 2D nanomaterials for gene delivery applications. Coord Chem Rev. 2017;347:77–97.
Yin T, Liu J, Zhao Z, Zhao Y, Dong L, Yang M, et al. Redox Sensitive Hyaluronic acid-decorated graphene oxide for photothermally controlled tumor-cytoplasm-selective rapid drug delivery. Adv Funct Mater. 2017;27:1604620.
Zhu C, Du D, Lin Y. Graphene-like 2D nanomaterial-based biointerfaces for biosensing applications. Biosens Bioelectron. 2017;89:43–55.
Choi CA, Lee JE, Mazrad ZAI, In I, Jeong JH, Park SY. Redox- and pH-responsive fluorescent carbon nanoparticles-MnO2-based FRET system for tumor-targeted drug delivery in vivo and in vitro. J Ind Eng Chem. 2018;63:208–19.
Huang G, Zhang K-L, Chen S, Li S-H, Wang L-L, Wang L-P, et al. Manganese-iron layered double hydroxide: a theranostic nanoplatform with pH-responsive MRI contrast enhancement and drug release. J Mater Chem B. 2017;5:3629–33.
Kalantar-zadeh K, Ou JZ, Daeneke T, Mitchell A, Sasaki T, Fuhrer MS. Two dimensional and layered transition metal oxides. Appl Mater Today. 2016;5:73–89.
Li Z, Wong SL. Functionalization of 2D transition metal dichalcogenides for biomedical applications. Mater Sci Engineering: C. 2017;70:1095–106.
Yang D, Feng L, Dougherty CA, Luker KE, Chen D, Cauble MA, et al. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide. Biomaterials. 2016;104:361–71.
Alibolandi M, Mohammadi M, Taghdisi SM, Ramezani M, Abnous K. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery. Carbohydr Polym. 2017;155:218–29.
Oh J-M, Choi S-J, Kim S-T, Choy J-H. Cellular Uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrin-mediated endocytosis. Bioconjug Chem. 2006;17:1411–7.
Tang L, Xie X, Li C, Xu Y, Zhu W, Wang L. Regulation of structure and anion-exchange performance of layered double hydroxide: function of the metal cation composition of a Brucite-like Layer. Materials. 2022;15: 7983.
Peng L, Mei X, He J, Xu J, Zhang W, Liang R, et al. Monolayer nanosheets with an extremely high drug loading toward controlled delivery and cancer theranostics. Adv Mater. 2018;30:1707389.
Zhu X, Ji X, Kong N, Chen Y, Mahmoudi M, Xu X, et al. Intracellular mechanistic understanding of 2D MoS2 nanosheets for anti-exocytosis-enhanced synergistic cancer therapy. ACS Nano. 2018;12:2922–38.
Hashemi H, Namazi H. Understanding the pH dependent fluorescence and doxorubicin release from graphene oxide functionalized citric acid dendrimer as a highly efficient drug delivery system. Mater Today Commun. 2021;28: 102593.
Boddu A, Obireddy SR, Zhang D, Rao KSVK, Lai W-F. ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy. Drug Deliv. 2022;29:2481–90.
Mohammadzadeh V, Norouzi A, Ghorbani M. Multifunctional nanocomposite based on lactose@layered double hydroxide-hydroxyapatite as a pH-sensitive system for targeted delivery of doxorubicin to liver cancer cells. Colloids Surf Physicochem Eng Asp. 2022;651: 129723.
Xu S, Zhong Y, Nie C, Pan Y, Adeli M, Haag R. Co-delivery of doxorubicin and chloroquine by polyglycerol functionalized MoS2 nanosheets for efficient multidrug-resistant cancer therapy. Macromol Biosci. 2021;21:2100233.
Li R, Wang Y, Du J, Wang X, Duan A, Gao R, et al. Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy. Sci Rep. 2021;11:1725.
He S, Li J, Chen M, Deng L, Yang Y, Zeng Z, et al. Graphene oxide-template gold nanosheets as highly efficient near-infrared hyperthermia agents for cancer therapy. Int J Nanomed. 2020;15:8451–63.
Liu W, Zhang X, Zhou L, Shang L, Su Z. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy. J Colloid Interface Sci. 2019;536:160–70.
Zhang X, Wu J, Williams GR, Niu S, Qian Q, Zhu L-M. Functionalized MoS2-nanosheets for targeted drug delivery and chemo-photothermal therapy. Colloids Surf B Biointerfaces. 2019;173:101–8.
Tahini HA, Tan X, Smith SC. The origin of low workfunctions in OH terminated MXenes. Nanoscale. 2017;9:7016–20.
Khazaei M, Arai M, Sasaki T, Ranjbar A, Liang Y, Yunoki S. OH-terminated two-dimensional transition metal carbides and nitrides as ultralow work function materials. Phys Rev B. 2015;92: 075411.
Xing C, Chen S, Liang X, Liu Q, Qu M, Zou Q, et al. Two-dimensional MXene (Ti3C2)-integrated cellulose hydrogels: toward smart three-dimensional network nanoplatforms exhibiting light-induced swelling and bimodal photothermal/chemotherapy anticancer activity. ACS Appl Mater Interfaces. 2018;10:27631–43.
Wen H, Liu P, Jiang Z, Peng H, Liu H. Redox-responsive MXene-SS-PEG nanomaterials for delivery of doxorubicin. Inorg Chem Commun. 2023;147: 110227.
Geng B, Xu S, Shen L, Fang F, Shi W, Pan D. Multifunctional carbon dot/MXene heterojunctions for alleviation of tumor hypoxia and enhanced sonodynamic therapy. Carbon N Y. 2021;179:493–504.
Seitak A, Shanti A, Al Adem K, Farid N, Luo S, Iskandarov J, et al. 2D MXenes for controlled releases of therapeutic proteins. J Biomed Mater Res A. 2023;111:514–26.
Liu G, Zou J, Tang Q, Yang X, Zhang Y, Zhang Q, et al. Surface modified Ti3C2 MXene nanosheets for tumor targeting photothermal/photodynamic/chemo synergistic therapy. ACS Appl Mater Interfaces. 2017;9:40077–86.
Rabiee N, Bagherzadeh M, Jouyandeh M, Zarrintaj P, Saeb MR, Mozafari M, et al. Natural polymers decorated MOF-MXene nanocarriers for co-delivery of doxorubicin/pCRISPR. ACS Appl Bio Mater. 2021;4:5106–21.
Wu Z, Shi J, Song P, Li J, Cao S. Chitosan/hyaluronic acid based hollow microcapsules equipped with MXene/gold nanorods for synergistically enhanced near infrared responsive drug delivery. Int J Biol Macromol. 2021;183:870–9.
Zhu B, Shi J, Liu C, Li J, Cao S. In-situ self-assembly of sandwich-like Ti3C2 MXene/gold nanorods nanosheets for synergistically enhanced near-infrared responsive drug delivery. Ceram Int. 2021;47:24252–61.
Darroudi M, Elnaz Nazari S, Karimzadeh M, Asgharzadeh F, Khalili-Tanha N, Asghari SZ, et al. Two-dimensional-Ti3C2 magnetic nanocomposite for targeted cancer chemotherapy. Front Bioeng Biotechnol. 2023;11:1097631.
Bai L, Yi W, Sun T, Tian Y, Zhang P, Si J, et al. Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer. J Mater Chem B. 2020;8:6402–17.
Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 2006;66:5216–23.
Santha Moorthy M, Bharathiraja S, Manivasagan P, Lee KD, Oh J. Crown ether triad modified core–shell magnetic mesoporous silica nanocarrier for pH-responsive drug delivery and magnetic hyperthermia applications. New J Chem. 2017;41:10935–47.
Santha Moorthy M, Bharathiraja S, Manivasagan P, Lee KD, Oh J. Synthesis of surface capped mesoporous silica nanoparticles for pH-stimuli responsive drug delivery applications. Medchemcomm. 2017;8:1797–805.
Bakhshian Nik A, Zare H, Razavi S, Mohammadi H, Torab Ahmadi P, Yazdani N, et al. Smart drug delivery: capping strategies for mesoporous silica nanoparticles. Microporous Mesoporous Mater. 2020;299: 110115.
Merino S, Martín C, Kostarelos K, Prato M, Vázquez E. Nanocomposite hydrogels: 3D polymer–nanoparticle synergies for on-demand drug delivery. ACS Nano. 2015;9:4686–97.
Dhas N, Parekh K, Pandey A, Kudarha R, Mutalik S, Mehta T. Two dimensional carbon based nanocomposites as multimodal therapeutic and diagnostic platform: a biomedical and toxicological perspective. J Controlled Release. 2019;308:130–61.
Darbasizadeh B, Fatahi Y, Feyzi-barnaji B, Arabi M, Motasadizadeh H, Farhadnejad H, et al. Crosslinked-polyvinyl alcohol-carboxymethyl cellulose/ZnO nanocomposite fibrous mats containing erythromycin (PVA-CMC/ZnO-EM): fabrication, characterization and in-vitro release and anti-bacterial properties. Int J Biol Macromol. 2019;141:1137–46.
Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol. 1992;116:1055–62.
Wang J, Liu J, Liu Y, Wang L, Cao M, Ji Y, et al. Gd-Hybridized plasmonic Au‐nanocomposites enhanced tumor‐interior drug permeability in multimodal imaging‐guided therapy. Adv Mater. 2016;28:8950–8.
Han X, Song Z, Zhou Y, Zhang Y, Deng Y, Qin J, et al. Mitochondria-targeted high-load sound-sensitive micelles for sonodynamic therapy to treat triple-negative breast cancer and inhibit metastasis. Mater Sci Engineering: C. 2021;124: 112054.
Yang Y, Yun K, Li Y, Zhang L, Zhao W, Zhu Z, et al. Self-assembled multifunctional polymeric micelles for tumor-specific bioimaging and synergistic chemo-phototherapy of cancer. Int J Pharm. 2021;602: 120651.
Qi S, Guo L, Yan S, Lee RJ, Yu S, Chen S. Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway. Acta Pharm Sin B. 2019;9:279–93.
Xue C-C, Li M-H, Zhao Y, Zhou J, Hu Y, Cai K-Y, et al. Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO3 nanoformulation triggers ferroptosis in target tumor cells. Sci Adv. 2020;6: 6.
Gazzi A, Fusco L, Khan A, Bedognetti D, Zavan B, Vitale F, et al. Photodynamic therapy based on Graphene and MXene in Cancer Theranostics. Front Bioeng Biotechnol. 2019;7:295.
Shramova EI, Chumakov SP, Shipunova VO, Ryabova AV, Telegin GB, Kabashin AV, et al. Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors. Light Sci Appl. 2022;11:38.
Yin Z, Ji Q, Wu D, Li Z, Fan M, Zhang H, et al. H2O2-Responsive gold nanoclusters @ mesoporous silica @ manganese dioxide nanozyme for off/on modulation and enhancement of magnetic resonance imaging and photodynamic therapy. ACS Appl Mater Interfaces. 2021;13:14928–37.
Jin J, Qiu S, Wang P, Liang X, Huang F, Wu H, et al. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. J Experimental Clin Cancer Res. 2019;38:377.
Li J, Xie L, Li B, Yin C, Wang G, Sang W, et al. Engineering a hydrogen-sulfide-based nanomodulator to normalize hyperactive photothermal immunogenicity for combination cancer therapy. Adv Mater. 2021;33:2008481.
Li Y, Fu R, Duan Z, Zhu C, Fan D. Artificial Nonenzymatic antioxidant MXene nanosheet-anchored injectable hydrogel as a mild photothermal-controlled oxygen release platform for diabetic wound healing. ACS Nano. 2022;16:7486–502.
Shi M, Wang Z-S, Huang L-Y, Dong J-J, Zheng X-Q, Lu J-L, et al. Utilization of albumin fraction from defatted rice bran to stabilize and deliver (-)-epigallocatechin gallate. Food Chem. 2020;311: 125894.
Liao T, Chen Z, Kuang Y, Ren Z, Yu W, Rao W, et al. Small-size Ti3C2Tx MXene nanosheets coated with metal-polyphenol nanodots for enhanced cancer photothermal therapy and anti-inflammation. Acta Biomater. 2023;159:312–23.
van Beek JJP, Wimmers F, Hato SV, de Vries IJM, Skold AE. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination. Crit Rev Immunol. 2014;34:517–36.
Dou Z, Ghosh K, Vizioli MG, Zhu J, Sen P, Wangensteen KJ, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017;550:402–6.
Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19:179–92.
Janda CY, Dang LT, You C, Chang J, de Lau W, Zhong ZA, et al. Surrogate wnt agonists that phenocopy canonical wnt and β-catenin signalling. Nature. 2017;545:234–7.
Cui D, Kong N, Ding L, Guo Y, Yang W, Yan F. Ultrathin 2D titanium carbide MXene (Ti3C2Tx) nanoflakes activate WNT/HIF-1α-mediated metabolism reprogramming for periodontal regeneration. Adv Healthc Mater. 2021;10:2101215.
Wei Y, Bao R, Hu L, Geng Y, Chen X, Wen Y, et al. Ti3C2 (MXene) nanosheets disrupt spermatogenesis in male mice mediated by the ATM/p53 signaling pathway. Biol Direct. 2023;18:30.
Guo Y, Terazzi E, Seemann R, Fleury JB, Baulin VA. Direct proof of spontaneous translocation of lipid-covered hydrophobic nanoparticles through a phospholipid bilayer. Sci Adv. 2016;2:2.
Xu KY, Takimoto E, Fedarko NS. Activation of (Na++ K+)-ATPase induces positive inotropy in intact mouse heart in vivo. Biochem Biophys Res Commun. 2006;349:582–7.
Lee DI, Klein MG, Zhu W, Xiao R-P, Gerzanich V, Xu KY. Activation of (Na++ K+)-ATPase modulates Cardiac L-Type Ca2 + Channel function. Mol Pharmacol. 2009;75:774–81.
Ma Y, Hinde E, Gaus K. Nanodomains in biological membranes. Essays Biochem. 2015;57:93–107.
Levental I, Veatch SL. The Continuing mystery of lipid rafts. J Mol Biol. 2016;428:4749–64.
Dong LM, Ye C, Zheng LL, Gao ZF, Xia F. Two-dimensional metal carbides and nitrides (MXenes): preparation, property, and applications in cancer therapy. Nanophotonics. 2020;9:2125–45.
Nasrallah GK, Al-Asmakh M, Rasool K, Mahmoud KA. Ecotoxicological assessment of Ti3C2Tx (MXene) using a zebrafish embryo model. Environ Sci Nano. 2018;5:1002–11.
Wen Y, Hu L, Li J, Geng Y, Yang Y, Wang J, et al. Exposure to two-dimensional ultrathin Ti3C2 (MXene) nanosheets during early pregnancy impairs neurodevelopment of offspring in mice. J Nanobiotechnol. 2022;20:108.
Liu X, Tang I, Wainberg ZA, Meng H. Safety considerations of cancer nanomedicine—a key step toward translation. Small. 2020;16:73.
https://www.fda.gov/media/109910/downloadDrug. (Accessed: Jan 2020).
Khan MI, Zahra Q, Batool A, Kalsoom F, Gao F, Ali S. Trends in nanotechnology to improve therapeutic efficacy across special structures. OpenNano. 2022;7:100049.
Abbas JJ, Smith B, Poluta M, Velazquez-Berumen A. Improving health-care delivery in low-resource settings with nanotechnology. Nanobiomedicine (Rij). 2017;4:184954351770115.
Acknowledgements
We are thankful to School of Health Sciences and Technology (SoHST), UPES, Dehradun, Uttarakhand, India.
Funding
There is no role of funding agencies to design this study materials and data interpretation.
Author information
Authors and Affiliations
Contributions
Vishal Kumar Deb: Writing – original draft, Writing – review & editing, Utkarsh Jain: Conceptualization, Supervision, Writing – review & editing.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Deb, V.K., Jain, U. Ti3C2 (MXene), an advanced carrier system: role in photothermal, photoacoustic, enhanced drugs delivery and biological activity in cancer therapy. Drug Deliv. and Transl. Res. (2024). https://doi.org/10.1007/s13346-024-01572-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s13346-024-01572-3